Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Nuti

Showing results (41-50 of 144) with videos related to

Pageof 15
Sort By:
Journal of Endocrinological Investigation|October 13, 2010
Bone fragility in men: where are we?R Nuti, D Merlotti, C M Francucci, et al.
Minerva Medica|January 28, 1984
[Effects of nandrolone decanoate on bone mineral content and intestinal absorption of calcium]R Nuti, G A Righi, V Turchetti, et al.
Minerva Endocrinologica|October 1, 1992
[Methodological basis and clinical applications of total-body densitometry]R Nuti, G Martini, B Frediani, et al.
Panminerva Medica|January 1, 1987
Effect of a long-term treatment with the aminosuberic analog of eel calcitonin on osteocalcin in Paget's diseaseA Caniggia, R Nuti, M Galli, et al.
Clinical Science and Molecular Medicine|September 1, 1976
Indirect evidence of calcitonin secretion in manA Caniggia, C Gennari, A Vattimo, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale|May 15, 1976
[Behavior of blood calcium after oral administration of glucose in subjects with defective intestinal transport of radiocalcium]M Montagnani, C Gennari, A Vattimo, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|October 12, 2010
Mechanisms of impaired bone strength in type 1 and 2 diabetesD Merlotti, L Gennari, F Dotta, et al.
Acta Vitaminologica Et Enzymologica|January 1, 1984
Clinical, biochemical and histological results of a double-blind trial with 1,25-dihydroxyvitamin D3, estradiol and placebo in post-menopausal osteoporosisA Caniggia, G Delling, R Nuti, et al.
Bone and Mineral|March 1, 1988
Total body and regional bone mineral analysis by dual-photon absorptiometry in Paget's disease of boneR Nuti, G Righi, V Turchetti, et al.
Drug Safety|September 1, 1994
Management of osteoporosis and Paget's disease. An appraisal of the risks and benefits of drug treatmentC Gennari, R Nuti, D Agnusdei, et al.
Pageof 15

Showing results (41-50 of 144) with videos related to

Sort By:
Pageof 15
Journal of Endocrinological Investigation|October 13, 2010
Bone fragility in men: where are we?R Nuti, D Merlotti, C M Francucci, et al.
Minerva Medica|January 28, 1984
[Effects of nandrolone decanoate on bone mineral content and intestinal absorption of calcium]R Nuti, G A Righi, V Turchetti, et al.
Minerva Endocrinologica|October 1, 1992
[Methodological basis and clinical applications of total-body densitometry]R Nuti, G Martini, B Frediani, et al.
Panminerva Medica|January 1, 1987
Effect of a long-term treatment with the aminosuberic analog of eel calcitonin on osteocalcin in Paget's diseaseA Caniggia, R Nuti, M Galli, et al.
Clinical Science and Molecular Medicine|September 1, 1976
Indirect evidence of calcitonin secretion in manA Caniggia, C Gennari, A Vattimo, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale|May 15, 1976
[Behavior of blood calcium after oral administration of glucose in subjects with defective intestinal transport of radiocalcium]M Montagnani, C Gennari, A Vattimo, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|October 12, 2010
Mechanisms of impaired bone strength in type 1 and 2 diabetesD Merlotti, L Gennari, F Dotta, et al.
Acta Vitaminologica Et Enzymologica|January 1, 1984
Clinical, biochemical and histological results of a double-blind trial with 1,25-dihydroxyvitamin D3, estradiol and placebo in post-menopausal osteoporosisA Caniggia, G Delling, R Nuti, et al.
Bone and Mineral|March 1, 1988
Total body and regional bone mineral analysis by dual-photon absorptiometry in Paget's disease of boneR Nuti, G Righi, V Turchetti, et al.
Drug Safety|September 1, 1994
Management of osteoporosis and Paget's disease. An appraisal of the risks and benefits of drug treatmentC Gennari, R Nuti, D Agnusdei, et al.
Pageof 15